Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells
2010
New Compounds to Fight Prostate Cancer by Restoring p27Kip1
Sample size: 7368
publication
Evidence: moderate
Author Information
Author(s): Elizabeth Rico-Bautista, Chih-Cheng Yang, Lifang Lu, Gregory P Roth, Dieter A Wolf
Primary Institution: Sanford-Burnham Medical Research Institute
Hypothesis
Can small molecules restore p27Kip1 protein expression in prostate cancer cells?
Conclusion
The study identified two small molecules, SMIP001 and SMIP004, that can restore p27 levels and inhibit cancer cell growth.
Supporting Evidence
- SMIP001 and SMIP004 increased nuclear p27 levels in prostate cancer cells.
- The compounds inhibited CDK2 activity and induced cell cycle delay.
- SMIP004 downregulated SKP2, leading to p27 stabilization.
Takeaway
Scientists found two new drugs that help a protein called p27 work better in prostate cancer cells, which can slow down cancer growth.
Methodology
A high throughput screening assay was developed using LNCaP prostate cancer cells to identify compounds that restore p27 levels.
Limitations
The exact molecular targets of the identified compounds remain unknown.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website